NPR's Michel Martin speaks with Ruth Faden, founder of the Berman Institute of Bioethics at Johns Hopkins University, about the ethics of determining who gets vaccinated when resources are limited.
NPR's Michel Martin speaks with Nadine Gartner, founder and executive director of Boost Oregon, about how to talk to people who may be resistant or afraid to get a coronavirus vaccine.
D.C.'s mayor urged the federal government to send more medicine to no avail. Now the states are sharing their supply to vaccinate health care workers who work in the capital but live elsewhere.
The Food and Drug Administration greenlights the biotech firm's vaccine for emergency use in the U.S. The move bolsters a vast inoculation effort that's already underway.
Despite being founded a decade ago, Moderna has never had a product make it to market. And the company registered its first factory with the Food and Drug Administration just this week.
An advisory panel to the Food and Drug Administration met on Thursday to review Moderna's application for emergency use authorization for its COVID-19 vaccine. NPR discusses the latest.
Atlantic writer Ed Yong says the COVID-19 vaccination program will be the most complicated the U.S. has ever attempted: "It's going to be a slow process, and there are a lot of possible roadblocks."